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Abstract: Background: Understanding how cancer incidence evolves during economic growth is useful for forecasting 
the economic impact of cancerous diseases, and for governing the process of resources allocation in planning health 
services. We analyse the relationship between economic growth and cancer incidence in order to describe and measure 
the influence of an increasing real per capita income on the overall rate of cancer incidence. 
Method: We test the relationship between real per capita income and the overall rate of cancer incidence with a cross-
sectional analysis, using data from the World Bank and the World Health Organization databases, for 165 countries in 
2008. We measure the elasticity of cancer incidence with respect to per capita income, and we decompose the 
elasticities coefficients into two components: age-effect and lifestyle-effect.  
Results: An Engel’s model, in a double-log quadratic specification, explains about half of the variations in the age-
standardised rates and nearly two thirds of the variations in the incidence crude rates. All the elasticities of the crude 
rates are positive, but less than one. The income elasticity of the age-standardised rates are negative in lower income 
countries, and positive (around 0.25 and 0.32) in upper middle and high income countries, respectively. 
Conclusions: These results are used to develop a basic framework in order to explain how demand-side economic 
structural changes may affect the long run evolution of cancer incidence. At theoretical level, a J-Curve is a possible 
general model to represents, other things being equal, how economic growth influence cancer incidence.  
Keywords: Cancer Incidence, Economic Growth, Engel’s function, Income elasticity, Structural Change. 
1. INTRODUCTION 
The importance of economic growth on population’s 
health conditions is difficult to overstate. At 
macroeconomic level, both theory [1] and empirical 
evidence [2] indicate that there is a positive causal 
relation between per capita income and some 
fundamental measures of health performance (e.g., life 
expectancy and infant mortality, among others). 
Overall, it seems that ‘wealthier nations are healthier 
nations’ [3]. 
During economic growth, however, every economy 
undergoes several substantial structural changes in 
healthcare demand and supply. Thereby, the process 
of economic growth modifies both composition and 
priority of society’s health problems. In particular, 
cancers and others non-communicable diseases, that 
once were considered the diseases of high income 
countries, are now frequently diagnosed in developing 
economies [4]. Understanding how cancer incidence 
evolves during economic growth is increasingly useful 
for forecasting the economic impact of cancerous  
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diseases, and for governing the process of resources 
allocation in planning health services [5]. However, 
there has been a scarcity of research about the long-
run macroeconomic determinants of cancer frequency 
[6]. 
This paper analyses the relationship between 
economic growth and cancer incidence at 
macroeconomic level, using worldwide cross-sectional 
data for 165 countries in 2008. First, we attempt to 
collect some empirical regularities concerning how an 
increasing real per capita income influences the overall 
rate of cancer of incidence. Second, we use these 
results to introduce some basic hypotheses about how 
economic structural changes may affect the evolution 
of cancer incidence. We emphasise that this is not a 
study about social and economic factors causing 
cancerous diseases, and the paper does not provide a 
complete account of the role of economic growth on 
cancer frequency. We simply highlights some basic 
empirical regularities and theoretical insights to be 
considered for further research, in order to start 
developing an economic theory of cancer incidence. 
The remainder of the paper is organized as follows. 
Section 2 briefly introduces the essential measures of 
cancer frequency. Section 3 summarizes some basic 
concepts of cancer aetiology. Sections 4 and 5 are 
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devoted to quantitative analysis. Section 6 contains a 
sketch of a theory of cancer incidence, within a simple 
structural economic dynamics framework. Finally, 
various objections can be raised to this work, and we 
discuss many of them in Section 7, that concludes the 
paper. 
2. CANCER EPIDEMIOLOGY: BRIEF CONCEPTS 
Cancer epidemiology studies the distribution and 
determinants of cancerous diseases in specified 
populations, and applies this knowledge to prevent and 
control cancer-related public health problems. 
Quantifying cancers occurrence in a given population is 
therefore an essential step in epidemiological studies 
[7].  
In order to describe and measure cancers 
frequency, epidemiology utilises, among others, three 
mains indicators: incidence, prevalence and mortality. 
Incidence and mortality are flow variables. They 
indicate the number of new cancer cases and the 
number of deaths due to cancer, respectively, which 
occur in a specific population, over a given period 
(usually 1 year). Prevalence is a stock variable. It 
indicates the number of cancer cases in a specific 
population at a given point in time (such as at the end 
of a given year). As in other stock–flow relationships, 
incidence, mortality and prevalence are closely related. 
Specifically, for a given average duration of the 
disease, prevalence is a function of incidence and 
mortality [8]. 
Data on incidence, prevalence and mortality are 
usually expressed as absolute numbers or as rates. 
Rates can be crude or age-standardised. A crude rate 
(cr) is calculated by dividing the absolute number of 
new cases, cases or deaths by the corresponding 
number of people in the population-at-risk. On the other 
hand, an age-standardised rate (sr) is a weighted 
average of the age-specific crude rates, where the 
weights are the proportion of people in the 
corresponding age groups of a specific standard 
population. Since cancer is not a single disease, but a 
collection of diverse yet related diseases, the 
population-at-risk is a subset of the total population 
under study (usually defined by sex and age) that 
include only the people who are potentially susceptible 
to develop one or the group of cancerous disease 
under consideration. The age-adjusted rates are 
calculated to allow comparison between populations 
with different age structures, and they are particularly 
useful in making international comparisons. In this 
case, the most frequently used standard population is 
the world standard population [9] and the results are 
usually presented as annual rates per 100,000 
persons-at-risk [10]. 
Where raw data are regularly collected by local 
cancer registry, these basic measures of cancer 
frequency can be computed for each type of cancers, 
usually classified according to the International 
Classification of Diseases (ICD), or for all cancerous 
diseases as a whole [11]. In this latter case, 
epidemiologists usually refer to the overall prevalence 
rate as a measure of society’s cancer burden. In the 
same way, since incidence is regarded as a useful 
approximation to the average risk of developing any 
type of cancer, the overall incidence rate is considered 
as an index of the level of cancer risk factors that exist 
in a given society, during a given period. Finally, the 
overall mortality rate provides an approximation to the 
average risk of dying from some type of cancer. 
3. CANCER RISK FACTORS AND CANCER 
INCIDENCE  
The term cancer refers to a broad group of diseases 
in which normal cells of a specific tissue change and 
start to do not function properly. In particular, mutated 
cells do not respond to regular cell cycle control signals 
and begin to grow and divide in an uncontrolled way. 
This population of abnormal cells is able to invade and 
destroy other nearby tissues and also to spread to 
other parts of the body, causing severe illness and 
death. 
Although all cancerous diseases begin in cells, with 
some kind of damage in genetic material, there is no 
one single factor to cause an healthy cell to become 
cancerous. Cancer is likely to be influenced by many 
variables. Different types of cancer usually share some 
basic causes, and at the same time each type of 
cancer has its own specific determinants. The 
transformation from a normal cell into a cancer cell is 
indeed a multistage and complex process. According to 
a large literature on cancer aetiology, however, this 
process is the result of the interaction between the 
inborn genetic characteristics of each individual and 
numerous external causes, that can be gathered and 
classified into three main categories: biological, 
chemical and physical carcinogens agents [12]. 
Genetic characteristics, along with external 
carcinogens agents, determine a set of cancer risk 
factors. A cancer risk factor is anything that may 
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increase an individual probability of developing some 
type of cancer. A risk factor itself does not necessarily 
cause the disease. Nevertheless, the frequency of 
cancers in a specific population is associated, ceteris 
paribus, with the intensity and the duration of people’s 
exposures to one or more risk factors. 
Specifically, the subset of the external carcinogens 
agents is strictly related to the general environmental 
and socio-economic conditions, as well as population 
habits and customs. Epidemiological studies suggest a 
long list of behaviours and situations associated with 
an increased cancer incidence. Tobacco and excessive 
alcohol consumption, qualitative and quantitative 
unhealthy nutrition, chemical contamination of food, air 
and water, lack of physical activity, unprotected 
exposure to ultraviolet and ionizing radiation, and 
chronic infection from some viruses are the main 
factors able to play an important role in causing 
cancers [13].  
By affecting the individual chance to become ill, all 
non-congenital cancer risk factors, taken as a whole, 
are a leading force that contributes to determine the 
overall rate of cancer incidence in a given population. 
But, a distinctive feature of these external cancer risk 
factors is that, at least partially, they are avoidable. 
Each combination of behaviours and situations 
associated with a low or a high risk to developing any 
type of cancer, reflects a given healthy or unhealthy 
lifestyle. Therefore, the population exposure to cancer 
risk factors changes when people modify their habits 
and customs, both directly via individual choices (such 
as variations in dietary components and eating 
patterns) and/or indirectly by means of collective 
choices (such as changes in regulation of 
environmental pollution and workplace conditions). 
4. METHODS AND DATA 
4.1. An Engel Function for Cancer Incidence 
Abstracting from the complexity of the causal 
interactions between different carcinogens agents and 
the process of cancer initiation and progression, at a 
macroeconomic level the relationship between cancer 
incidence and lifestyle-related factors may be 
described by a simple and single equation model, like: 
isr = f(q; )           (1) 
where the age-standardized rate of incidence for all 
type of cancers (isr) in a given population depends on 
the people’s exposure to external cancer risk factors 
(q), for a stated level of not avoidable agents due to 
individuals’ genetic characteristics (). 
In equation 1), q is a catchall variable that stands for 
all the behaviours and situations that characterize 
people habits and customs and it serves as a proxy for 
measuring the average population exposure to lifestyle 
cancer risk factors. One may think at q as a bundle of 
goods (such as foods) and/or bads (such as 
environmental pollutions), in which each item is 
described by the set of its healthy related attributes 
[14]. For instance, the safety and nutritional 
characteristics of foods that reflect a poor or a healthy 
eating habits. The whole set of these attributes 
determines a more or a less cancer risk prone lifestyle. 
In the short run, changes in relative prices may 
have some influence on q, but its main composition is 
likely to be about constant. On the other hand, in the 
long run the average population exposure to external 
cancer risk factors tends to undergo dramatic structural 
changes. In particular, as real per capita income 
increases there are successive income threshold levels 
where people shift their behaviours and start following 
a new lifestyle [15]. In each stage of development, the 
population consumption pattern follows a hierarchy of 
needs and wants (determined by many biological, 
cultural and social factors), so that as the average 
income rises, increases in consumption tends to 
concentrate on a particular group of goods with specific 
characteristics, and this group change, sometimes 
gradually and sometimes abruptly, from one level of 
real per capita income to another [16]. 
This is a well-known generalisation of the so-called 
‘Engel’s law’ [17]. It simply states that the proportion of 
income spent on each type of goods changes as real 
average income increases, because people modify 
their preferences, by means of both individual and 
collective choices, along a distinct hierarchy of needs
1
 
[18]. Put differently, the science and technology 
evolution that goes with economic growth, along with 
an increasing average purchasing power, deeply 
modifies people habits and customs. These changes in 
lifestyles causing transformations of the set of 
                                            
1
In a narrow meaning, an Engel’s curve ‘is the function describing how a 
consumer’s expenditures on some good or service relates to the consumer’s 
total resources, holding prices fixed, so qi = gi (y, z), where qi is the quantity 
consumed of good i, y is income, wealth, or total expenditures on goods and 
services, and z is a vector of other characteristics of the consumer, such as 
age and household composition’ [18]. In Engel’s function, q may measure the 
physical quantity consumed, or typically the aggregate expenditure for a group 
of goods or services. 
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attributes that enter the bundle of health-related goods 
(and bads) faced by the population and therefore they 
have a strong effects on population health-related 
consumption patterns. 
An aggregate Engel’s function, in which the average 
people exposure to external cancer risk factors (q) 
depends on the population real average income (y): 
q = g(y)            (2) 
albeit very simple, may be a useful tool to capture the 
influences of economic growth on cancer incidence. In 
effect, replacing q in equation 1) by its expression from 
equation 2), gives: 
isr = f [g(y); ]           (3) 
a relationship between real per capita income and the 
age-standardized rate of incidence, for a given level of 
the not avoidable cancer risk factors. 
4.2. Data on Cancer Incidence and Per Capita 
Income 
This paper focuses on the influence of economic 
growth on cancer incidence. In particular, we test the 
relationship between real per capita income and the 
overall rate of cancer incidence with a cross-sectional 
analysis, using data from the World Bank and the 
World Health Organization (WHO) databases, for 165 
countries in 2008. 
Specifically, real per capita income (y) is measured 
by the ratio of GNI to population and it is expressed in 
current international dollars, using purchasing power 
parity (PPP) exchange rates [19]. While, cancer 
incidence (isr) is measured by the age-standardised 
rate of all types of cancer – ‘all sites, but non 
melanoma skin’, according to the International 
Classification of Diseases – provided by the 
International Agency for Research on Cancer (IARC) 
within the Globocan project [20]. 
Especially in low and middle income countries, 
economic growth leads to remarkable rises in the 
average life expectation at birth. In the same countries, 
furthermore, changes in lifestyle due to an increasing 
purchasing power may be different between female 
and male population. Both, life expectation at birth and 
gender affect cancer incidence. Thus, even thought our 
analysis is at aggregate level, it is useful to measure 
cancer incidence with the crude rate (icr) together with 
isr, and also with both crude and age standardised 
rates computed separately for male (micr and misr) and 
female (ficr and fisr) population. Table 1 contains a 
short description and some basic descriptive statistics 
of all variables (the full database is available from the 
authors)
2
. 
5. RESULTS 
5.1. International Evidence of Income Elasticity of 
Cancer Incidence 
The simple scatter plots depicted in Figure 1, where 
variables are measured in natural logarithms, show for 
each country the pairs of observations on per capita 
income and the crude (Figure 1a) and age-
standardised rates (Figure 1b) of cancer incidence in 
                                            
2
The complete database contains 169 observation. However, there are four 
very small oil countries (namely, Brunei Darussalam, Kuwait, Qatar and United 
Arab Emirates) that both visual inspection and influence statistics quite clearly 
indicate as outlier.  
Table 1: Variables and Descriptive Statistics 
Description Variable Mean Std. Dev. Min Max 
Gross National Income Per Capita y 11,874.96 13,205.43 286.66 64,943.33 
Both sex, Incidence Crude Rate icr 192.6 161.4 44.6 589.7 
Both sex, Incidence Age-Standardized Rate isr 162.9 67.2 72.2 326.1 
Male, Incidence Crude Rate micr 188.2 143.7 45.4 590.6 
Male, Incidence Age-Standardized Rate misr 155.8 55.7 69.3 325.3 
Female, Incidence Crude Rate ficr 200.9 183.0 33.4 648.0 
Female, Incidence Age-Standardized Rate fisr 175.8 86.4 68.6 360.6 
Gross National Income per capita in PPP, current international $. 
Three years average (2006, 2007 and 2008). Source: World Development Indicators, World Bank. 
Crude and Age-Standardized rates per 100.000 persons. All ages and all types of cancers. 
Estimated cancer incidence for 2008 (all sites, but non melanoma skin: C00-C96, but C44). 
Source: Globocan 2.0 - International Agency for Research on Cancer, World Health Organization. 
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the whole (female and male) population. Both graphs 
seem to suggest a strong influence of real per capita 
income on the average risk of developing some type of 
cancer. Indeed, the correlation coefficients between 
log(y) and log(icr) or log(isr) are, respectively, 0.78 and 
0.69 (Table 1A in Appendix). The same pattern of 
relationship, with only slightly differences, appears if 
one plots both the crude and the age standardised 
rates against real per capita income, but separately for 
male and female populations, as shown in Figure 1A in 
Appendix. 
A straightforward procedure for quantifying the 
‘sensitivity’ of cancer incidence with respect to the 
process of economic growth, is to estimates a double-
log model, with the log of incidence rate as dependent 
variable and the log of per capita income as 
explanatory variable, that is: log(iri) = 0 + 1log(yi). 
Indeed, in the double-log model the estimated slope 
parameter (1) is itself a coefficient of elasticity (), that 
measures the relative change in the dependent 
variable for a given relative change in the explanatory 
variable [21].  
A constant elasticity function, however, is not able 
to capture the complex interactions between economic 
growth and the population health conditions. Both, the 
direction and the extent of the influence of the growth 
process on the people exposure to external cancer risk 
factors are likely to be remarkable different at different 
stages of social and economic development. In order to 
model the full range of possible influences, it is 
preferable to utilize a more flexible specification, such 
as a combined logarithmic and polynomial functional 
form, as follows: 
log(iri) = 0 + 1log(yi) + 2[log(yi)]2 + i        (3) 
where  is the stochastic error term. This is a double-
log quadratic regression model that allows a non 
constant elasticity. Specifically, the income elasticity of 
cancer incidence, IR: 
IR = (dir/dy)  (y/ir) = 1 + 22log(yi)         (4) 
may be either negative or positive, and in turn when IR 
has a positive sign it may be less or greater than one 
[22].  
An attempt to develop a quantitative assessment of 
the influences of economic growth on cancer incidence, 
using model in equation 3), is summarised in Table 2. 
Although, the use of natural logs contributes to 
moderate potential problems due to heteroskedasticity, 
all equations are estimated using the White's 
coefficient covariance matrix in order to obtain 
heteroskedasticity robust standard errors [23]. The 
goodness of fit is fairly high in all equations. 
Movements in real per capita income are able to 
    
    a        b 
Figures 1: a and b. GNI per capita and cancer incidence, in both sex (smooth line indicates the Nearest Neighbor Fit, Lowess 
function, span = 0.3). 
F
r A
uth
or'
s P
ers
o
al 
Us
e
280     International Journal of Statistics in Medical Research, 2013 Vol. 2, No. 4 Ferretti et al. 
explain about half of the variations in the age-
standardised rates and nearly two thirds of the 
variations in the crude rates of cancer incidence. All 
estimated regression coefficients are strongly 
statistically significant (p-values are always less than 
0.01). Moreover, the decomposition of total population 
by sex does not alter the main outcomes. There is only 
a slight reduction in the goodness of fit for the 
regression using the age-standardised rate within the 
female population. 
These results confirm the intuitive finding from the 
visual inspection of Figure 1. The process of economic 
growth plays a crucial role on the determination of the 
rates of cancer incidence. More specifically, the 
significance of coefficient 2 in all regressions indicates 
that the elasticity of cancer incidence with respect to 
income is not likely to be constant as development 
proceeds and the real average income rises. The 
estimated regression coefficients 1 and 2, along with 
equation 4), allow us to compute the income elasticity 
of cancer incidence: that is, the percentage change in 
the rate of cancer incidence when real per capita 
income changes by 1 percent. The results of these 
calculations are collected in Table 3, where countries 
Table 2: Regression Results 
Dependent variable Regressor Coefficient Std. Error t-Statistic Prob. Adj. R-sq. n 
Constant 7.375 1.155 6.384 <0.0001 
Log(y) -1.104 0.279 -3.949 0.0001 Log(icr) 
[Log(y)]
2 
0.093 0.016 5.623 <0.0001 
0.65 165 
Constant 7.267 0.764 9.514 <0.0001 
Log(y) -0.767 0.181 -4.228 <0.0001 Log(isr) 
[Log(y)]
2 
0.057 0.010 5.421 <0.0001 
0.54 165 
Constant 7.643 1.072 7.129 <0.0001 
Log(y) -1.105 0.259 -4.265 <0.0001 Log(ficr) 
[Log(y)]
2 
0.089 0.015 5.892 <0.0001 
0.64 165 
Constant 7.679 0.756 10.156 <0.0001 
Log(y) -0.822 0.179 -4.586 <0.0001 Log(fisr) 
[Log(y)]
2 
0.058 0.010 5.545 <0.0001 
0.47 165 
Constant 6.884 1.306 5.271 <0.0001 
Log(y) -1.068 0.315 -3.386 0.0009 Log(micr) 
[Log(y)]
2 
0.095 0.018 5.087 <0.0001 
0.66 165 
Constant 6.689 0.839 7.964 <0.0001 
Log(y) -0.679 0.199 -3.399 0.0008 Log(misr) 
[Log(y)]
2 
0.055 0.011 4.760 <0.0001 
0.56 165 
Table 3: Elasticities of Cancer Incidence and Development Stage* 
 
Low 
income 
GNI per capita 
($1,025 or less) 
Lower 
middle income 
GNI per capita 
($1,026 to $4,035) 
 
Average 
Upper 
middle income 
GNI per capita 
($4,036 to $12,475) 
High 
income 
GNI per capita 
($12,476 or more) 
Average 
icr 0.127 0.326 0.226 0.545 0.780 0.663 
isr -0.008 0.115 0.053 0.250 0.395 0.323 
ficr 0.087 0.279 0.183 0.492 0.719 0.605 
fisr -0.056 0.068 0.006 0.205 0.351 0.278 
micr 0.129 0.326 0.227 0.545 0.780 0.663 
misr 0.058 0.117 0.117 0.308 0.449 0.378 
*World Bank’s classification by GNI per capita (World Bank, 2012). 
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are classified in four main groups, according to the 
World Bank ranking of economies by their GNI per 
capita [24].  
All the elasticities of the crude rates are positive but 
less than one. They are, on average, around 0.2 in the 
low and middle income countries and about 0.6 in the 
more developed economies. Furthermore, it is worthy 
to notice that coefficients concerning the age-
standardised rates are about a half and one third of 
those computed for the crude rates in richer and poorer 
countries, respectively. In words, there are both a gross 
and a net effect of economic growth on cancer 
incidence. The former includes the positive influence of 
an increasing real per capita income on the average 
duration of life, while the latter measures the reactivity 
of cancer incidence to economic growth due only to 
changes in health related population lifestyles. Figure 2 
provides an idea of the evolution of both gross and net 
effects of economic growth on cancer incidence in the 
total population at different development stages. 
Only the income elasticity of the age-standardised 
rates (ISR) are a correct measure of the magnitude of 
the influence of economic growth on population 
exposure to external cancer risk factors. These 
elasticity coefficients are both negative and positive. 
Negative, or around zero, values of ISR are found in 
low and lower middle income countries. The reactivity 
of cancer incidence to per capita income increases in 
richer countries, however it remains rather inelastic, 
around 0.25 and 0.32 in upper middle and high income 
societies, respectively. Finally, an interesting result is 
the difference between ISR in male and female 
population, especially in the poorer countries.  
5.2. The Delay Between Onset and Exposure and 
the Inter-Country Variability 
In brief, cancer incidence depends on the 
population exposure to external cancer risk factors 
which, in turn, depends on the level of development, 
ceteris paribus. Changes in income, therefore, lead to 
changes in lifestyle, and thus to changes in new cancer 
cases. 
But, as in other non-communicable diseases (like, 
for example, the cardio-vascular diseases), there is a 
delay between the illness onset and the exposure to 
risk factors, that is ‘today’s incidence rate is affected by 
yesterday’s exposure, and today’s exposure will affect 
tomorrow’s incidence rate’. To capture this temporal 
lag, we rewrite the econometric model as follows: 
isrt = f [g(yt-n); ]  log(isrit) = 0 + 1log(yit-n) + 
2[log(yit-n)]2 + i           (4) 
where isrt is the rate of cancer incidence in year t and 
yt-n is the per capita income n years before t. We 
estimate equation 4), using data on y in 1990 (before 
1990 the sample become too small, and strongly 
biased towards the developed countries).  
 
Figure 2: Income elasticity of CR and ASR, in both sex. 
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The temporal lag effect is a crucial issue in every 
study that examines the relation between the exposure 
to particular external risk factor and the onset of a 
specific type of cancer (for instance, between tobacco 
consumption and the insurgence of lung cancer), with 
time series data. Nevertheless, in our macroeconomic 
analysis that relates cancer incidence to per capita 
income, using cross sectional data, the delay between 
y and isr tends to show an important quantitative role, 
but only a minor effect on the characteristics of the 
relationship. In Table 4 are collected regression results 
for the age-standardised rates as dependent variables 
and the GNI per capita in 1990 as explanatory variable. 
The sample now includes 140 observations (all 
countries of the full database for which the World Bank 
provides data on y measured in PPP terms for 1990). A 
list of countries included in the two samples are 
compiled in Table 2A in Appendix. There are no 
significant differences between output of regressions 
with lagged and non-lagged income. On average, the 
goodness of fit is now slightly higher, and all 
coefficients remains strongly significant (except for the 
linear component in equation for the male population).  
However, the delay between average people 
exposure and the illness onset affects the income 
elasticity of cancer incidence, as shown in Table 5. On 
average, all coefficients are now slightly greater than 
those with non-lagged y. But, the main characteristics 
of the relationship still remain the same. Anyway, the 
differences between IR computed with yt-n and y are a 
useful indirect measure of the importance of temporal 
lag effect of economic growth on cancer incidence. 
Finally, in our worldwide samples there is great 
variability. Countries differ not only in terms of their 
income per capita but also, and perhaps mainly, in 
ethnic, cultural and other socio-economic 
characteristics. A basic strategy to deal with this 
problem is the use of one or more dummy variables. 
We make a first attempt to reduce inter-country 
variability by creating a new variable, w. In particular, w 
is an intercept dummy variable, that assumes value 1 if 
the country is characterised by a ‘western lifestyle’, and 
0 otherwise
3
. Regression results, using GNI per capita 
in 1990, and with a simplified double-log model, are 
collected in Table 6. The variable w is highly significant 
in all equations. Thus, the relation between income per 
capita and cancer incidence shifts upward when w 
equals 1. This evidence allow us to make a distinction 
between a movement along the ‘y-ir curve’, and a shift 
in the ‘y-ir curve’. The former is due to a change (that 
is, an increase) in per capita income, ceteris paribus. 
On the other hand, changes in variables included in the 
set of the cancer risk factors cause an upward (or a 
downward) shift in the aggregate Engel’s function 
between y and ir. 
6. DISCUSSION 
6.1. On the Macroeconomic Determinants of Cancer 
Incidence 
In modern theories of economic growth, technical 
change has a key role in explaining the determinants of 
population’s standard of living [25]. In particular, when 
inventions and innovations relax and change the 
technological constraints, the economic system 
undergoes a complex process of transformational 
growth [26]. More specifically, on the one side, 
technical change means a flow of both new production 
                                            
3
We include in this subset all European countries, plus Australia, Canada, New 
Zealand and the United States of America. 
Table 4: Regression Results with 1990 GNI Per Capita 
Dependent variable Regressor Coefficient Std. Error t-Statistic Prob. Adj. R-sq. n 
Constant 7.318 0.903 8.104 <0.0001 
Log(y90) -0.828 0.230 -3.591 0.0005 Log(isr) 
[Log(y90)]
2 
0.066 0.014 4.583 <0.0001 
0.55 140 
Constant 8.011 0.874 9.165 <0.0001 
Log(y90) -0.957 0.224 -4.279 <0.0001 Log(fisr) 
[Log(y90)]
2 
0.070 0.014 5.065 <0.0001 
0.49 140 
Constant 6.394 1.042 6.131 <0.0001 
Log(y90) -0.649 0.265 -2.450 0.0155 Log(misr) 
[Log(y90)]
2 
0.058 0.016 3.570 <0.0001 
0.58 140 
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techniques and new (or better) goods available to 
producers and consumers. On the other side, it means 
an increasing productivity of resources and therefore a 
higher and higher amount of wages and profits that 
goes to workers and capitalists or, more generally, an 
increasing trend in real average income [27]. 
Technical change, and therefore economic growth, 
affects cancer incidence, prevalence and mortality in 
various ways. In particular, at macroeconomic level, 
changes in cancer frequency are primarily due to some 
relevant structural changes operating on the supply 
and demand sides of the economy, respectively (as 
shown in Figure 3). 
Let us first consider the production effects. As the 
growth process progresses, better medical and surgical 
treatments, and notably, better techniques for early 
diagnosis become available (and usually affordable) to 
a large proportion of population. These medical 
improvements are able to dramatically reduce the 
mortality of cancers. This is why in each society, other 
things being equal, for a given incidence rate economic 
growth implies a notable increase in prevalence rates. 
However the supply-side influences of economic 
growth may also be negative. In fact, the new products 
and production processes discovered in the past 
sometimes reveal harmful effects, and therefore affects 
today incidence rates. 
Let us now consider the consumption effects. We 
denote with qLOW and qHIGH two specific combinations of 
bads and goods that reflects a lifestyle characterised 
by a low and a high risk of developing any type of 
cancer, respectively. Specifically, qLOW indicates a set 
of behaviours and situations associated with a 
minumum level of the average population exposure to 
the external cancer risk factors, and vice versa for 
qHIGH. It seems reasonable to think at qLOW (that is, to 
think at ‘an anti-cancer lifestyle’) as a sort of luxury 
good, with an income elasticity coefficient greater than 
one, and at qHIGH as a normal (or inferior) good, that is 
a good with an income elasticity positive, but always 
less than one (or negative, in the case of inferior 
good)
4
. 
In general, because of the existence of a hierarchy 
of needs, one observes that the demand for a luxury 
good, at aggregate level, tends to remain weak until 
                                            
4
Epidemiological data on tobacco and alcohol consumption, for example, 
seems to support this hypothesis, both are necessities (or inferior) goods in 
most of the developed countries and luxuries in a majority of developing 
countries [28-29]. 
Table 5: Elasticities of Cancer Incidence and Development Stage in 1990 
 
Low 
income 
GNI per capita 
($1,025 or less) 
Lower 
middle income 
GNI per capita 
($1,026 to $4,035) 
Average 
Upper 
middle income 
GNI per capita 
($4,036 to $12,475) 
High 
income 
GNI per capita 
($12,476 or more) 
Average 
isr 0.018 0.173 0.095 0.324 0.463 0.393 
fisr -0.049 0.117 0.034 0.280 0.429 0.354 
misr 0.104 0.242 0.173 0.377 0.500 0.438 
 
Table 6: Regression Results with Dummy Variable (1990 GNI Per Capita) 
Dependent variable Regressor Coefficient Std. Error t-Statistic Prob. Adj. R-sq. n 
Constant 3.804 0.180 21.11 <0.0001 
Log(y90) 0.138 0.024 5.608 <0.0001 Log(isr) 
w
 
0.423 0.063 6.706 <0.0001 
0.63 140 
Constant 4.113 0.165 24.84 <0.0001 
Log(y90) 0.098 0.022 4.373 <0.0001 Log(fisr) 
w
 
0.370 0.060 6.156 <0.0001 
0.54 140 
Constant 3.433 0.209 16.35 <0.0001 
Log(y90) 0.186 0.028 6.518 <0.0001 Log(misr) 
w 0.485 0.071 6.749 <0.0001 
0.67 140 
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real average income reaches a threshold critical level, 
and after that it starts to increasing sharply. By 
affecting the demand for qLOW and qHIGH, economic 
growth modifies the average composition of q, 
positively (i.e., towards qLOW) or negatively (i.e., 
towards qHIGH) and in turn it changes the average 
population exposure to external cancer risk factors. 
At less developed stages of social and economic 
conditions the process of growth usually pushes 
populations towards an unhealthy ‘western lifestyle’, 
such as smoking and consumption of calorie-dense 
food. Furthermore, in these circumstance economic 
growth is often driven by an industrialization process 
based upon high polluting production methods, that 
typically take place in unsafe and harmful working 
environment. As growth progresses and the average 
income overcomes a threshold level, changes in both 
individual and collective preferences lead to an 
increase in demand for an healthy lifestyle. As a result, 
the effects of economic growth on cancer incidence 
gradually turn from negative to positive. Finally, all 
these complex supply and demand side influences on 
incidence and mortally ends in determining the extent 
of cancer prevalence. 
6.2. A J-Curve Hypothesis 
At theoretical level, some kind of J-Curve is a 
possible general model to represents, other things 
being equal, how economic growth influence cancer 
incidence in a given homogeneous population. This 
complex relationship may be captured by some basic 
hypotheses, as illustrated in Figure 4, where cancer 
incidence is measured by the age-standardised rate of 
all types of cancer (isr) at time t and economic growth 
is measured by the real per capita income (y) at time t-
n. At very low income levels, there is often a high 
incidence of cancers related to some biological (i.e., 
infectious) agents. Until y1, the positive effects of 
economic growth on general hygiene and sanitary 
conditions lead to a decrease in the future overall rate 
of cancer incidence. However, there will be a threshold 
minimum level that measures the autonomous 
component of the incidence rate (that is, isrMIN is 
independent of income, because it is weakly influenced 
by exposure to external risk factors, such as in the type 
of cancers with an important genetic aetiology). 
Beyond y1, cancer incidence will rise with economic 
growth. More specifically, there is an early range of 
development stages (from y1 to y*) in which increases 
in real per capita income have a more-than-
proportional, negative, effect on the overall rate of 
cancer incidence. When average income became 
greater than y* as a result of the expansion of demand 
for the anti-cancer lifestyle this more-than-proportional 
relationship tends to disappear. Cancer incidence will 
continue to rise, but less than proportional with respect 
to y. Economic growth returns to exert a positive effect 
on population exposure to external cancer risk factors 
only after y**, where isr reaches his maximum. Finally, 
when the development stage pass this threshold level, 
 
Figure 3: Negative and positive effects of economic growth on cancer incidence and mortality. 
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the overall rate of age-standardized cancer incidence 
might start decreasing. 
7. CONCLUSIONS 
This paper simply highlights some basic empirical 
regularities and theoretical insights that may be useful 
in developing an economic theory of the evolution of 
cancer incidence in a growing economy. Measuring 
and describing the relationship between cancer 
incidence and per capita income, however, constitutes 
only a first step in understanding how the process of 
economic growth may affect a population’s exposure to 
cancer causing factors. 
Furthermore, a number of important limitations need 
to be considered. First, incidence data are usually 
derived from population-based cancer registries, and 
thus there is a problem of data reliability in poorest 
countries, where the low level of development makes 
the information collection process more complicated. 
Second, there are well-known detection biases that 
make cancer more likely to appear incident in countries 
with an efficient health system. As a result, in 
developing countries the income elasticity of cancer 
incidence may be higher than our estimates. Third, the 
relation between economic growth and cancer 
incidence should be investigated through longitudinal 
studies. Long-run data on cancer frequency, however, 
are available only for a small set of high developed 
countries. Fourth, in our study we use a polynomial 
models, because the aim of the paper is simply to 
collect some ‘stylized facts’ about cancer incidence and 
economic growth. But, in order to forecast the impact of 
economic growth on cancer incidence this model may 
not be flexible enough, and some nonparametric 
models could work better. 
Finally, per capita income is not an accurate and 
adequate measure of a country’s level of development, 
and it is not possible to summarize with y a set of 
ethnical, cultural, economic, social and health features. 
Further research is needed to include more variables 
(as, for example, those referring to personal income 
distribution, cultural habits and customs, general 
sanitary conditions and health policies). It would be 
also necessary to utilise disaggregated epidemiological 
data for single type of cancer, and within more 
homogeneous genetic populations.  
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Figure 4: A J-Curve model for per capita income and cancer incidence in a given population (isr is measured at time t, and y is 
measured at time t-n). 
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APPENDIX 
Table 1A: Correlation Coefficients Table 
 Log(icr) Log(isr) Log(micr) Log(misr) Log(ficr) Log(fisr) 
Log(y) 0.78 0.69 0.79 0.73 0.77 0.63 
 (16.15) (12.48) (16.78) (13.74) (15.56) (10.45) 
p-value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Note: t-statistics in parentheses. 
 
   
a 
    
b 
Figure 1A: a. GNI per capita and cancer incidence, in male population (smooth line indicates the Nearest Neighbor Fit, Lowess 
function, span = 0.3). 
b. GNI per capita and cancer incidence, in female population (smooth line indicates the Nearest Neighbor Fit, Lowess function, 
span = 0.3). 
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Table 2A: List of Countries 
Sample 165 countries 
Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas The, Bahrain, Bangladesh, Barbados, 
Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina,, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, 
Cameroon, Canada, Cape Verde, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Dem. Rep., Congo, Rep., Costa 
Rica, Cote d'Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Ecuador, Egypt, Arab Rep., El Salvador, 
Equatorial Guinea, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia The, Georgia, Germany, Ghana, Greece, Guatemala, 
Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran Islamic Rep., Iraq, Ireland, Israel, Italy, Jamaica, 
Japan, Jordan, Kazakhstan, Kenya, Korea, Rep., Kyrgyz Republic, Lao PDR, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania,, 
Luxembourg, Macedonia (FYR), Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Mauritania, Mauritius, Mexico, Moldova, Mongolia, 
Montenegro, Morocco, Mozambique, Namibia, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Norway, Oman, Pakistan, 
Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Russian Federation, Rwanda, Samoa, Saudi Arabia, 
Senegal, Serbia, Sierra Leone, Singapore, Slovak Republic, Slovenia, Solomon Islands, South Africa, Spain, Sri Lanka, Sudan, Suriname, 
Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Trinidad and Tobago, Tunisia, 
Turkey, Turkmenistan, Uganda, Ukraine, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Venezuela (RB), Vietnam, Yemen 
Rep., Zambia, Zimbabwe. 
Sample 140 countries (GNI per capita 1990) 
Albania, Algeria, Angola, Argentina, Armenia, Australia, Austria, Bahamas The, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, 
Bhutan, Bolivia, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Chile, 
China, Colombia, Comoros, Congo, Dem. Rep., Congo, Rep., Costa Rica, Cote d'Ivoire, Cyprus, Denmark, Dominican Republic, Ecuador, 
Egypt, Arab Rep., El Salvador, Equatorial Guinea, Ethiopia, Fiji, Finland, France, Gabon, Gambia The, Georgia, Germany, Ghana, Greece, 
Guatemala, Guinea, Guinea-Bissau, Guyana, Honduras, Hungary, Iceland, India, Indonesia, Iran Islamic Rep., Ireland, Israel, Italy, Japan, 
Jordan, Kenya, Korea, Rep., Kyrgyz Republic, Lao PDR, Latvia, Lebanon, Lesotho, Lithuania, Luxembourg, Macedonia (FYR), Madagascar, 
Malawi, Malaysia, Mali, Malta, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Morocco, Mozambique, Namibia, Nepal, Netherlands, New 
Zealand, Nicaragua, Niger, Nigeria, Norway, Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Portugal, Romania, 
Russian Federation, Rwanda, Samoa, Senegal, Sierra Leone, Singapore, Slovak Republic, Solomon Islands, South Africa, Spain, Sri Lanka, 
Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Tanzania, Thailand, Togo, Trinidad and Tobago, 
Tunisia, Turkey, Uganda, Ukraine, United Kingdom, United States, Uruguay, Vanuatu, Venezuela (RB), Vietnam, Yemen Rep., Zambia. 
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